Treatment After JAKi in Patients with Rheumatoid Arthritis
This study, presented by Professor of Medicine and Rheumatology Janet Pope, highlights the effectiveness of cycling JAK inhibitors (JAKi) of different classes compared with switching to a biological disease-modifying antirheumatic drug (bDMARD) in patients with rheumatoid arthritis (RA) after failure to the first JAKi.
Få tilgang
Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.
- Få tilgang
- Hvis du allerede har en profil: Logg in
